ID   EPHB4_HUMAN             Reviewed;         987 AA.
AC   P54760; Q9BTA5; Q9BXP0;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   18-OCT-2001, sequence version 2.
DT   02-NOV-2010, entry version 125.
DE   RecName: Full=Ephrin type-B receptor 4;
DE            EC=2.7.10.1;
DE   AltName: Full=Tyrosine-protein kinase TYRO11;
DE   AltName: Full=Tyrosine-protein kinase receptor HTK;
DE   Flags: Precursor;
GN   Name=EPHB4; Synonyms=HTK, TYRO11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=94245746; PubMed=8188704;
RA   Bennett B.D., Wang Z., Kuang W.J., Wang A., Groopman J.E.,
RA   Goeddel D.V., Scadden D.T.;
RT   "Cloning and characterization of HTK, a novel transmembrane tyrosine
RT   kinase of the EPH subfamily.";
RL   J. Biol. Chem. 269:14211-14218(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=21138439; PubMed=11239002; DOI=10.1093/nar/29.6.1352;
RA   Wilson M.D., Riemer C., Martindale D.W., Schnupf P., Boright A.P.,
RA   Cheung T.L., Hardy D.M., Schwartz S., Scherer S.W., Tsui L.-C.,
RA   Miller W., Koop B.F.;
RT   "Comparative analysis of the gene-dense ACHE/TFR2 region on human
RT   chromosome 7q22 with the orthologous region on mouse chromosome 5.";
RL   Nucleic Acids Res. 29:1352-1365(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 143-987.
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-590 AND TYR-596, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=15951569; DOI=10.1074/mcp.M500089-MCP200;
RA   Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,
RA   Lauffenburger D.A., White F.M.;
RT   "Time-resolved mass spectrometry of tyrosine phosphorylation sites in
RT   the epidermal growth factor receptor signaling network reveals dynamic
RT   modules.";
RL   Mol. Cell. Proteomics 4:1240-1250(2005).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-590 AND TYR-774, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=17389395; DOI=10.1073/pnas.0608638104;
RA   Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
RT   "Multiple reaction monitoring for robust quantitative proteomic
RT   analysis of cellular signaling networks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-769; TYR-774; SER-911;
RP   THR-953 AND THR-976, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-976, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-976, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-574; TYR-774 AND
RP   TYR-987, AND MASS SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=19534553; DOI=10.1021/pr900044c;
RA   Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,
RA   Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,
RA   Wiley H.S., Qian W.-J.;
RT   "An extensive survey of tyrosine phosphorylation revealing new sites
RT   in human mammary epithelial cells.";
RL   J. Proteome Res. 8:3852-3861(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-574; TYR-614; SER-769;
RP   SER-770; TYR-774; THR-775; SER-776; TYR-906; SER-907; SER-911; THR-976
RP   AND TYR-987, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   STRUCTURE BY NMR OF 434-529.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the second FN3 domain from human ephrin type-B
RT   receptor 4.";
RL   Submitted (JUL-2007) to the PDB data bank.
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-67; ILE-113; LEU-346; VAL-371;
RP   GLU-576; HIS-678; THR-882; TRP-889 AND ASP-890.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor for members of the ephrin-B family. Binds to
CC       ephrin-B2. May have a role in events mediating differentiation and
CC       development.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in placenta and in a
CC       range of primary tissues and malignant cell lines. Expressed in
CC       fetal, but not adult, brain, and in primitive and myeloid, but not
CC       lymphoid, hematopoietic cells.
CC   -!- PTM: Autophosphorylated.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Ephrin receptor subfamily.
CC   -!- SIMILARITY: Contains 2 fibronectin type-III domains.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SAM (sterile alpha motif) domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U07695; AAA20598.1; -; mRNA.
DR   EMBL; AF312032; AAK21010.1; -; Genomic_DNA.
DR   EMBL; BC004264; AAH04264.1; -; mRNA.
DR   IPI; IPI00289342; -.
DR   PIR; A54092; A54092.
DR   RefSeq; NP_004435.3; -.
DR   UniGene; Hs.437008; -.
DR   PDB; 2BBA; X-ray; 1.65 A; A=17-196.
DR   PDB; 2E7H; NMR; -; A=434-529.
DR   PDB; 2HLE; X-ray; 2.05 A; A=17-196.
DR   PDB; 2QKQ; X-ray; 2.10 A; A/B=896-977.
DR   PDB; 2VWU; X-ray; 2.00 A; A=598-887.
DR   PDB; 2VWV; X-ray; 1.90 A; A=598-899.
DR   PDB; 2VWW; X-ray; 1.90 A; A=598-899.
DR   PDB; 2VWX; X-ray; 1.65 A; A=598-899.
DR   PDB; 2VWY; X-ray; 1.65 A; A=598-899.
DR   PDB; 2VWZ; X-ray; 1.65 A; A=598-899.
DR   PDB; 2VX0; X-ray; 2.10 A; A=598-899.
DR   PDB; 2VX1; X-ray; 1.65 A; A=598-899.
DR   PDBsum; 2BBA; -.
DR   PDBsum; 2E7H; -.
DR   PDBsum; 2HLE; -.
DR   PDBsum; 2QKQ; -.
DR   PDBsum; 2VWU; -.
DR   PDBsum; 2VWV; -.
DR   PDBsum; 2VWW; -.
DR   PDBsum; 2VWX; -.
DR   PDBsum; 2VWY; -.
DR   PDBsum; 2VWZ; -.
DR   PDBsum; 2VX0; -.
DR   PDBsum; 2VX1; -.
DR   ProteinModelPortal; P54760; -.
DR   SMR; P54760; 318-413, 322-529, 590-901.
DR   IntAct; P54760; 12.
DR   STRING; P54760; -.
DR   PhosphoSite; P54760; -.
DR   DOSAC-COBS-2DPAGE; P54760; -.
DR   PRIDE; P54760; -.
DR   Ensembl; ENST00000358173; ENSP00000350896; ENSG00000196411.
DR   GeneID; 2050; -.
DR   KEGG; hsa:2050; -.
DR   UCSC; uc003uwn.1; human.
DR   CTD; 2050; -.
DR   GeneCards; GC07M100402; -.
DR   H-InvDB; HIX0025312; -.
DR   HGNC; HGNC:3395; EPHB4.
DR   HPA; CAB013537; -.
DR   MIM; 600011; gene.
DR   PharmGKB; PA27827; -.
DR   eggNOG; prNOG04086; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG062180; -.
DR   InParanoid; P54760; -.
DR   OMA; YIKVDTV; -.
DR   OrthoDB; EOG9PZMS0; -.
DR   PhylomeDB; P54760; -.
DR   BRENDA; 2.7.10.1; 247.
DR   Pathway_Interaction_DB; ephbfwdpathway; EPHB forward signaling.
DR   Pathway_Interaction_DB; ephrinbrevpathway; Ephrin B reverse signaling.
DR   Pathway_Interaction_DB; ephrinb_ephbpathway; EphrinB-EPHB pathway.
DR   NextBio; 8335; -.
DR   ArrayExpress; P54760; -.
DR   Bgee; P54760; -.
DR   CleanEx; HS_EPHB4; -.
DR   Genevestigator; P54760; -.
DR   GermOnline; ENSG00000196411; Homo sapiens.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005003; F:ephrin receptor activity; IEA:InterPro.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0009887; P:organ morphogenesis; TAS:ProtInc.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0045765; P:regulation of angiogenesis; NAS:UniProtKB.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kin...; IEA:InterPro.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd.
DR   InterPro; IPR008957; Fibronectin_III_dom.
DR   InterPro; IPR003961; FN_III.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM_type.
DR   InterPro; IPR021129; SAM_type1.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR010993; Sterile_alpha_motif_homology.
DR   InterPro; IPR011641; Tyr-kin_ephrin_A/B_rcpt-like.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   InterPro; IPR020769; Tyr_prot_kinase_EphB_rcpt.
DR   InterPro; IPR016257; Tyr_prot_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_prot_kinase_rcpt_V_CS.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 2.
DR   Gene3D; G3DSA:1.10.150.50; SAM_type; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   PANTHER; PTHR23256:SF279; Tyr_prot_kinase_EphB_rcpt; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07699; GCC2_GCC3; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00536; SAM_1; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF49265; FN_III-like; 2.
DR   SUPFAM; SSF49785; Gal_bind_like; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF47769; SAM_homology; 1.
DR   PROSITE; PS01186; EGF_2; UNKNOWN_1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Glycoprotein; Kinase;
KW   Membrane; Nucleotide-binding; Phosphoprotein; Polymorphism; Receptor;
KW   Repeat; Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase.
FT   SIGNAL        1     15       Potential.
FT   CHAIN        16    987       Ephrin type-B receptor 4.
FT                                /FTId=PRO_0000016834.
FT   TOPO_DOM     16    539       Extracellular (Potential).
FT   TRANSMEM    540    560       Helical; (Potential).
FT   TOPO_DOM    561    987       Cytoplasmic (Potential).
FT   DOMAIN      323    428       Fibronectin type-III 1.
FT   DOMAIN      434    526       Fibronectin type-III 2.
FT   DOMAIN      615    899       Protein kinase.
FT   DOMAIN      907    971       SAM.
FT   NP_BIND     621    629       ATP (By similarity).
FT   MOTIF       985    987       PDZ-binding (Potential).
FT   COMPBIAS    184    320       Cys-rich.
FT   ACT_SITE    740    740       Proton acceptor (By similarity).
FT   BINDING     647    647       ATP (By similarity).
FT   MOD_RES     574    574       Phosphotyrosine.
FT   MOD_RES     614    614       Phosphotyrosine.
FT   MOD_RES     769    769       Phosphoserine.
FT   MOD_RES     770    770       Phosphoserine.
FT   MOD_RES     774    774       Phosphotyrosine.
FT   MOD_RES     775    775       Phosphothreonine.
FT   MOD_RES     776    776       Phosphoserine.
FT   MOD_RES     906    906       Phosphotyrosine.
FT   MOD_RES     907    907       Phosphoserine.
FT   MOD_RES     911    911       Phosphoserine.
FT   MOD_RES     953    953       Phosphothreonine.
FT   MOD_RES     976    976       Phosphothreonine.
FT   MOD_RES     987    987       Phosphotyrosine.
FT   CARBOHYD    203    203       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    335    335       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    426    426       N-linked (GlcNAc...) (Potential).
FT   VARIANT      67     67       P -> L (in dbSNP:rs34653459).
FT                                /FTId=VAR_042181.
FT   VARIANT     113    113       V -> I (in dbSNP:rs55866373).
FT                                /FTId=VAR_042182.
FT   VARIANT     346    346       P -> L (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_042183.
FT   VARIANT     371    371       A -> V (in dbSNP:rs55720981).
FT                                /FTId=VAR_042184.
FT   VARIANT     576    576       D -> E (in dbSNP:rs36050247).
FT                                /FTId=VAR_042185.
FT   VARIANT     678    678       R -> H (in dbSNP:rs55692440).
FT                                /FTId=VAR_042186.
FT   VARIANT     882    882       A -> T (in dbSNP:rs34918225).
FT                                /FTId=VAR_042187.
FT   VARIANT     889    889       R -> W (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042188.
FT   VARIANT     890    890       E -> D (in dbSNP:rs35638378).
FT                                /FTId=VAR_042189.
FT   CONFLICT     62     62       D -> E (in Ref. 1; AAA20598).
FT   CONFLICT    308    308       Y -> D (in Ref. 1; AAA20598).
FT   CONFLICT    464    464       V -> W (in Ref. 1; AAA20598).
FT   CONFLICT    926    927       ES -> AR (in Ref. 1; AAA20598).
FT   STRAND       17     22
FT   HELIX        23     25
FT   STRAND       33     36
FT   STRAND       43     48
FT   STRAND       54     61
FT   STRAND       63     65
FT   STRAND       70     74
FT   STRAND       84     95
FT   HELIX        97     99
FT   STRAND      109    121
FT   STRAND      130    132
FT   STRAND      135    142
FT   STRAND      160    166
FT   STRAND      171    182
FT   STRAND      184    196
FT   STRAND      441    446
FT   STRAND      449    453
FT   STRAND      460    462
FT   STRAND      466    473
FT   TURN        479    481
FT   STRAND      482    496
FT   STRAND      503    510
FT   HELIX       612    614
FT   STRAND      615    623
FT   STRAND      625    634
FT   STRAND      642    649
FT   HELIX       656    668
FT   STRAND      679    683
FT   STRAND      685    694
FT   HELIX       701    707
FT   TURN        708    710
FT   HELIX       714    733
FT   HELIX       743    745
FT   STRAND      746    748
FT   STRAND      754    756
FT   HELIX       784    786
FT   HELIX       789    794
FT   HELIX       799    814
FT   TURN        820    823
FT   HELIX       826    834
FT   HELIX       847    856
FT   HELIX       861    863
FT   HELIX       867    879
FT   HELIX       881    885
FT   HELIX       912    918
FT   HELIX       922    924
FT   HELIX       925    930
FT   HELIX       936    939
FT   HELIX       944    950
FT   HELIX       955    965
SQ   SEQUENCE   987 AA;  108270 MW;  11A004622F194706 CRC64;
     MELRVLLCWA SLAAALEETL LNTKLETADL KWVTFPQVDG QWEELSGLDE EQHSVRTYEV
     CDVQRAPGQA HWLRTGWVPR RGAVHVYATL RFTMLECLSL PRAGRSCKET FTVFYYESDA
     DTATALTPAW MENPYIKVDT VAAEHLTRKR PGAEATGKVN VKTLRLGPLS KAGFYLAFQD
     QGACMALLSL HLFYKKCAQL TVNLTRFPET VPRELVVPVA GSCVVDAVPA PGPSPSLYCR
     EDGQWAEQPV TGCSCAPGFE AAEGNTKCRA CAQGTFKPLS GEGSCQPCPA NSHSNTIGSA
     VCQCRVGYFR ARTDPRGAPC TTPPSAPRSV VSRLNGSSLH LEWSAPLESG GREDLTYALR
     CRECRPGGSC APCGGDLTFD PGPRDLVEPW VVVRGLRPDF TYTFEVTALN GVSSLATGPV
     PFEPVNVTTD REVPPAVSDI RVTRSSPSSL SLAWAVPRAP SGAVLDYEVK YHEKGAEGPS
     SVRFLKTSEN RAELRGLKRG ASYLVQVRAR SEAGYGPFGQ EHHSQTQLDE SEGWREQLAL
     IAGTAVVGVV LVLVVIVVAV LCLRKQSNGR EAEYSDKHGQ YLIGHGTKVY IDPFTYEDPN
     EAVREFAKEI DVSYVKIEEV IGAGEFGEVC RGRLKAPGKK ESCVAIKTLK GGYTERQRRE
     FLSEASIMGQ FEHPNIIRLE GVVTNSMPVM ILTEFMENGA LDSFLRLNDG QFTVIQLVGM
     LRGIASGMRY LAEMSYVHRD LAARNILVNS NLVCKVSDFG LSRFLEENSS DPTYTSSLGG
     KIPIRWTAPE AIAFRKFTSA SDAWSYGIVM WEVMSFGERP YWDMSNQDVI NAIEQDYRLP
     PPPDCPTSLH QLMLDCWQKD RNARPRFPQV VSALDKMIRN PASLKIVARE NGGASHPLLD
     QRQPHYSAFG SVGEWLRAIK MGRYEESFAA AGFGSFELVS QISAEDLLRI GVTLAGHQKK
     ILASVQHMKS QAKPGTPGGT GGPAPQY
//
